Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-pfhbr Total loading time: 0 Render date: 2024-07-09T20:13:33.699Z Has data issue: false hasContentIssue false

Chapter 26 - Contraception in Women with Psychiatric Conditions

from Section 2A - Sexual and Reproductive Healthcare: Contraception

Published online by Cambridge University Press:  16 January 2024

Johannes Bitzer
Affiliation:
University Women's Hospital, Basel
Tahir A. Mahmood
Affiliation:
Victoria Hospital, Kirkcaldy
Get access

Summary

This chapter discusses major depression (MD) as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria [1]. Mood changes and irritability in the context of hormonal contraception (HC) are discussed in Chapter 17. The most relevant symptoms of MD patients are demonstrated in Table 26.1. Patients with MD are no more capable to function in their daily life.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

WHO: Prevalence of mental disorders. https://bit.ly/3wPpx4F.Google Scholar
Pagano, HP, Zapata, LB, Berry-Bibee, EN et al. Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: A systematic review. Contraception. 2016;94(6):641–9.CrossRefGoogle ScholarPubMed
Robakis, T, Williams, KE, Nutkiewicz, L, Rasgon, NL. Hormonal contraceptives and mood: Review of the literature and implications for future research. Curr Psychiatry Rep. 2019;21(7):57.CrossRefGoogle ScholarPubMed
Skovlund, CW, Morch, LS, Kessing, LV, Lidegaard, O. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73(11):1154–62.CrossRefGoogle ScholarPubMed
De Wit, AE, Booij, SH, Giltay, EJ et al. Association of use of oral contraceptives with depressive symptoms among adolescents and young women. JAMA Psychiatry. 2019.CrossRefGoogle Scholar
Merki-Feld, GS, Apter, D, Bartfai, G et al. ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives. Eur J Contracept Reprod Health Care. 2017;22(4):247–9.CrossRefGoogle ScholarPubMed
Civic, D, Scholes, D, Ichikawa, L et al. Depressive symptoms in users and non-users of depot medroxyprogesterone acetate. Contraception. 2000;61(6):385–90.CrossRefGoogle ScholarPubMed
Westhoff, C, Wieland, D, Tiezzi, L. Depression in users of depo-medroxyprogesterone acetate. Contraception. 1995;51(6):351–4.CrossRefGoogle ScholarPubMed
Worly, BL, Gur, TL, Schaffir, J. The relationship between progestin hormonal contraception and depression: A systematic review. Contraception. 2018;97(6):478–89.CrossRefGoogle ScholarPubMed
Rasgon, N, Bauer, M, Glenn, T et al. Menstrual cycle related mood changes in women with bipolar disorder. Bipolar Disord. 2003;5(1):4852.CrossRefGoogle ScholarPubMed
Berenson, AB, Asem, H, Tan, A, Wilkinson, GS. Continuation rates and complications of intrauterine contraception in women diagnosed with bipolar disorder. Obstet Gynecol. 2011;118(6):1331–6.CrossRefGoogle ScholarPubMed
Tsai, R, Schaffir, J. Effect of depot medroxyprogesterone acetate on postpartum depression. Contraception. 2010;82(2):174–7.CrossRefGoogle ScholarPubMed
Charlson, FJ, Ferrari, AJ, Santomauro, DF et al. Global epidemiology and burden of schizophrenia: Findings from the Global Burden of Disease Study 2016. Schizophr Bull. 2018;44(6):11951203.CrossRefGoogle ScholarPubMed
Disease GBD, Injury I, Prevalence C: Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59.Google Scholar
Gonzalez-Rodriguez, A, Guardia, A, Alvarez Pedrero, A et al. Women with schizophrenia over the life span: Health promotion, treatment and outcomes. Int J Environ Res Public Health. 2020;17(15):n.p.CrossRefGoogle ScholarPubMed
Merki-Feld, GS, Bitzer, J. Contraception in adolescents with anorexia nervosa: Is there evidence for a negative impact of combined hormonal contraceptives on bone mineral density and the course of the disease? Eur J Contracept Reprod Health Care. 2020;25(3):213–20.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×